[1] YOUNOSSI Z,TACKE F,ARRESE M,et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Hepatology,2019,69(6):2672-2682.
|
[2] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64(1):73-84.
|
[3] CHALASANI N,YOUNOSSI Z,LAVINE JE,et al. The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J]. Gastroenterology,2012,142(7):1592-1609.
|
[4] HAGSTROM H,NASR P,EKSTEDT M,et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD[J]. J Hepatol,2017,67(6):1265-1273.
|
[5] VILAR-GOMEZ E,CALZADILLA-BERTOT L,WAI-SUN WONG V,et al. Fibrosis severity as a determinant of causespecific mortality in patients with advanced nonalcoholic fatty liver disease:A multi-national cohort study[J]. Gastroenterology,2018,155(2):443-457.
|
[6] FENG G,HAN HJ,Ql X,et al. Establishment of a noninvasive diagnosis equation for nonalcoholic fatty liver disease[J]. J Clin Hepatol,2018,34(6):1264-1267.(in Chinese)冯巩,韩海静,齐雪,等.非酒精性脂肪性肝病无创性诊断方程的构建[J].临床肝胆病杂志,2018,34(6):1264-1267.
|
[7] FENG G,HE N,ZHOU YF,et al. A simpler diagnostic formula for screening nonalcoholic fatty liver disease[J]. Clin Biochem,2019,64:18-23.
|
[8] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):947-957.
|
[9] Expert Committee on consensus on clinical application of transient elastography(TE). Expert consensus on clinical application of transient elastography(TE)(2015)[J/CD]. Chin J Liver Dis(Electronic Version),2015,7(2):12-18.(in Chinese)瞬时弹性成像技术(TE)临床应用共识专家委员会.瞬时弹性成像技术(TE)临床应用专家共识(2015年)[J/CD].中国肝脏病杂志(电子版),2015,7(2):12-18.
|
[10] NAIBANTOGLU IL,BRUNT EM. Role of liver biopsy in nonalcoholic fatty liver disease[J]. World J Gastroenterol,2014,20(27):9026-9037.
|
[11] PARK CC,NGUYEN P,HERNANDEZ C,et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease[J]. Gastroenterology,2017,152(3):598-607.
|
[12] BEDOSSA P,PATEL K. Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease[J].Gastroenterology,2016,150(8):1811-1822.
|
[13] PATEL PJ,CHENG JC,BANH X,et al. Clinically significant fibrosis is associated with longitudinal increases in Fibrosis-4and nonalcoholic fatty liver disease fibrosis scores[J]. Clin Gastroenterol Hepatol,2020,18(3):710-718.
|